SlideShare a Scribd company logo
1 of 61
An Overview of the Pharmaceutical Industry Syed Adeel Ahmed Business Development Manager Atco Laboratories Limited May 21, 2010
Global View of the Industry May 21, 2010
Global Company Sales May 21, 2010
Global Company Sales May 21, 2010
Global Company Sales May 21, 2010
The Past, Connecting Future ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],May 21, 2010
Growth Trend of the Global Industry May 21, 2010 Growth trend
Top products (by sales 06) May 21, 2010
Top products (by sales 06) May 21, 2010
Top products (by sales 06) May 21, 2010
Overview of Industry in Pakistan May 21, 2010
Macro Analysis of Pakistan Pharma market  (last 5 fiscal years) May 21, 2010 Rs. Million IMS Health
Local Company Sales May 21, 2010 Fiscal year 07-08
The Players May 21, 2010 Fiscal year 07-08
The Players May 21, 2010 Fiscal year 07-08 Total companies:  681 Share of top-50:  84%
Therapeutics May 21, 2010 Fiscal year 07-08
Disease Profile of Pakistan May 21, 2010
May 21, 2010 ,[object Object],In Pakistan….
May 21, 2010 ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Major Contributor of CVD
May 21, 2010 ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Major Contributor of CVD
May 21, 2010 Diabetes, a Growing Global Crisis Adapted from Zimmet P et al.  Diabet Med . 2003;20:693-702. 30 million people in 1985 189 million people in 2003 324 million projected for 2025 72% increase Diabetes mellitus is a very serious public health problem which prevalence is increasing rapidly 25.0 39.7 59% 10.4 19.7 88% 38.2 44.2 16% 1.1 1.7 59% 13.6 26.9 98% 81.8 156.1 91% 18.2 35.9 97%
May 21, 2010 Rank Country 1995    Country 2025 (million)  (million) 1 India 19.4   India 57.2 2 China 16   China 37.6 3 U.S. 13.9   U.S. 21.9 4 Russian Federation 8.9   Pakistan 14.5 5 Japan 6.3   Indonesia 12.4 6 Brazil 4.9   Russian Federation 12.2 7 Indonesia 4.5   Mexico 11.7 8 Pakistan 4.3   Brazil 11.6 9 Mexico 3.8   Egypt 8.8 14 Ukraine 3.6   Japan 8.5 All other countries 49.7 103.6 Total 135.3 300.0 Prevalence of Diabetes in World
Hepatitis C ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],May 21, 2010
Hepatitis C ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],May 21, 2010
Top Products (by sales 07-08) May 21, 2010
Top Products (by sales 07-08) May 21, 2010
Top Products (by sales 07-08) May 21, 2010
Pharmaceutical Marketing Mix May 21, 2010 Product Place Promotion Price P P P P
The Product ,[object Object],[object Object],May 21, 2010
The Product ,[object Object],[object Object],[object Object],May 21, 2010
The Product ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],May 21, 2010
The Price ,[object Object],[object Object],May 21, 2010
The Price ,[object Object],[object Object],May 21, 2010
The Price ,[object Object],[object Object],[object Object],[object Object],[object Object],May 21, 2010
The Price ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],May 21, 2010
Promotion Pharmaceutical Marketing May 21, 2010
May 21, 2010 HOME Patients visits a Dr  Doctor Rx  Distributor Drug Factory Drug Buying Behavior Reps  visits a Dr  Dr write prescription Buying Process Pharmacy
Pharmaceutical Marketing ,[object Object],[object Object],[object Object],May 21, 2010
Pharmaceutical Marketing ,[object Object],[object Object],[object Object],May 21, 2010
Direct and indirect marketing to health care providers ,[object Object],[object Object],[object Object],May 21, 2010
Direct and indirect marketing to health care providers ,[object Object],[object Object],May 21, 2010
Direct and indirect marketing to health care providers ,[object Object],[object Object],May 21, 2010
Direct and indirect marketing to health care providers ,[object Object],[object Object],May 21, 2010
Direct and indirect marketing to health care providers ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],May 21, 2010
Direct physician contact with pharma sales reps ,[object Object],[object Object],May 21, 2010
Direct physician contact with pharma sales reps ,[object Object],May 21, 2010
Direct physician contact with pharma sales reps ,[object Object],[object Object],May 21, 2010
Physician Targeting ,[object Object],May 21, 2010
Physician Targeting ,[object Object],May 21, 2010
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Physician Targeting May 21, 2010
Opinion Leader Influence Mapping ,[object Object],May 21, 2010
Opinion Leader Influence Mapping ,[object Object],May 21, 2010
Sales force size and structure ,[object Object],[object Object],May 21, 2010
[object Object],Sales force size and structure May 21, 2010
Place (of distribution) ,[object Object],[object Object],May 21, 2010
Place (of distribution) ,[object Object],[object Object],[object Object],May 21, 2010
Regulations on Pharmaceutical Industry May 21, 2010
What is regulated? ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],May 21, 2010
International Marketing (Exports) of Pharmaceuticals from Pakistan May 21, 2010
Exports ,[object Object],May 21, 2010
Thank you …  May 21, 2010

More Related Content

What's hot

Competitive landscape of the pharma industry in india
Competitive landscape of the pharma industry in indiaCompetitive landscape of the pharma industry in india
Competitive landscape of the pharma industry in india123sripal
 
GlaxoSmithKline Pakistan Pharmaceutical company
GlaxoSmithKline Pakistan Pharmaceutical companyGlaxoSmithKline Pakistan Pharmaceutical company
GlaxoSmithKline Pakistan Pharmaceutical companyRida Shad
 
Export potentiality of pharmaceutical goods in Bangladesh
Export potentiality  of pharmaceutical goods in BangladeshExport potentiality  of pharmaceutical goods in Bangladesh
Export potentiality of pharmaceutical goods in BangladeshSaifur Rahman Samrat
 
Competitive Analysis in Pharmaceutical Industry
Competitive Analysis in Pharmaceutical IndustryCompetitive Analysis in Pharmaceutical Industry
Competitive Analysis in Pharmaceutical IndustryYee Jie NG
 
Abbott laboratories
Abbott laboratoriesAbbott laboratories
Abbott laboratoriesSyeda Zeerak
 
Present Status and Scope of Pharmaceutical industry in India
Present Status and Scope of Pharmaceutical industry in IndiaPresent Status and Scope of Pharmaceutical industry in India
Present Status and Scope of Pharmaceutical industry in IndiaMadhuraNewrekar
 
Pakistan government debt
Pakistan government debtPakistan government debt
Pakistan government debtShahWazir1
 
Pharma industry 1-4_9_29_50
Pharma industry 1-4_9_29_50Pharma industry 1-4_9_29_50
Pharma industry 1-4_9_29_50domsr
 
Debt Managment in Pakistan
Debt Managment in PakistanDebt Managment in Pakistan
Debt Managment in PakistanGhulam Hasnain
 
Pharmaceutical industry India
Pharmaceutical industry IndiaPharmaceutical industry India
Pharmaceutical industry IndiaSushant Mishra
 
indian Pharmaceutical industry export import overview
indian Pharmaceutical industry export import overviewindian Pharmaceutical industry export import overview
indian Pharmaceutical industry export import overviewbipindapin
 
| Balance of Payment | BOP | Balance of Payment and Pakistan | Differences Be...
| Balance of Payment | BOP | Balance of Payment and Pakistan | Differences Be...| Balance of Payment | BOP | Balance of Payment and Pakistan | Differences Be...
| Balance of Payment | BOP | Balance of Payment and Pakistan | Differences Be...Ahmad Hassan
 
DPCO-Drug price control order
DPCO-Drug price control orderDPCO-Drug price control order
DPCO-Drug price control orderANANT NAG
 
Indian pharmaceutical industry
Indian pharmaceutical industry Indian pharmaceutical industry
Indian pharmaceutical industry Kushal Shah
 
PRESENT SCENARIO OF INDIAN PHARMACEUTICAL INDUSTRY IN VIEW OF GLOBAL ...
PRESENT  SCENARIO  OF  INDIAN  PHARMACEUTICAL  INDUSTRY IN  VIEW  OF  GLOBAL ...PRESENT  SCENARIO  OF  INDIAN  PHARMACEUTICAL  INDUSTRY IN  VIEW  OF  GLOBAL ...
PRESENT SCENARIO OF INDIAN PHARMACEUTICAL INDUSTRY IN VIEW OF GLOBAL ...sridivyaannavarapu
 
Marketing of a pharma (Basic)
Marketing of a pharma (Basic)Marketing of a pharma (Basic)
Marketing of a pharma (Basic)Arsalan Humayun
 
Pakistan economy and debts on pakistan
Pakistan economy and debts on pakistanPakistan economy and debts on pakistan
Pakistan economy and debts on pakistanshahidbangash258
 
Glaxosmithkline portfolio
Glaxosmithkline portfolioGlaxosmithkline portfolio
Glaxosmithkline portfolioVinay Desai
 

What's hot (20)

Competitive landscape of the pharma industry in india
Competitive landscape of the pharma industry in indiaCompetitive landscape of the pharma industry in india
Competitive landscape of the pharma industry in india
 
GlaxoSmithKline Pakistan Pharmaceutical company
GlaxoSmithKline Pakistan Pharmaceutical companyGlaxoSmithKline Pakistan Pharmaceutical company
GlaxoSmithKline Pakistan Pharmaceutical company
 
Export potentiality of pharmaceutical goods in Bangladesh
Export potentiality  of pharmaceutical goods in BangladeshExport potentiality  of pharmaceutical goods in Bangladesh
Export potentiality of pharmaceutical goods in Bangladesh
 
Competitive Analysis in Pharmaceutical Industry
Competitive Analysis in Pharmaceutical IndustryCompetitive Analysis in Pharmaceutical Industry
Competitive Analysis in Pharmaceutical Industry
 
Abbott laboratories
Abbott laboratoriesAbbott laboratories
Abbott laboratories
 
Present Status and Scope of Pharmaceutical industry in India
Present Status and Scope of Pharmaceutical industry in IndiaPresent Status and Scope of Pharmaceutical industry in India
Present Status and Scope of Pharmaceutical industry in India
 
Pakistan government debt
Pakistan government debtPakistan government debt
Pakistan government debt
 
Pfizer
PfizerPfizer
Pfizer
 
Pharma industry 1-4_9_29_50
Pharma industry 1-4_9_29_50Pharma industry 1-4_9_29_50
Pharma industry 1-4_9_29_50
 
Debt Managment in Pakistan
Debt Managment in PakistanDebt Managment in Pakistan
Debt Managment in Pakistan
 
Pharmaceutical industry India
Pharmaceutical industry IndiaPharmaceutical industry India
Pharmaceutical industry India
 
indian Pharmaceutical industry export import overview
indian Pharmaceutical industry export import overviewindian Pharmaceutical industry export import overview
indian Pharmaceutical industry export import overview
 
| Balance of Payment | BOP | Balance of Payment and Pakistan | Differences Be...
| Balance of Payment | BOP | Balance of Payment and Pakistan | Differences Be...| Balance of Payment | BOP | Balance of Payment and Pakistan | Differences Be...
| Balance of Payment | BOP | Balance of Payment and Pakistan | Differences Be...
 
DPCO-Drug price control order
DPCO-Drug price control orderDPCO-Drug price control order
DPCO-Drug price control order
 
Indian pharmaceutical industry
Indian pharmaceutical industry Indian pharmaceutical industry
Indian pharmaceutical industry
 
Indian pharma industry
Indian pharma industryIndian pharma industry
Indian pharma industry
 
PRESENT SCENARIO OF INDIAN PHARMACEUTICAL INDUSTRY IN VIEW OF GLOBAL ...
PRESENT  SCENARIO  OF  INDIAN  PHARMACEUTICAL  INDUSTRY IN  VIEW  OF  GLOBAL ...PRESENT  SCENARIO  OF  INDIAN  PHARMACEUTICAL  INDUSTRY IN  VIEW  OF  GLOBAL ...
PRESENT SCENARIO OF INDIAN PHARMACEUTICAL INDUSTRY IN VIEW OF GLOBAL ...
 
Marketing of a pharma (Basic)
Marketing of a pharma (Basic)Marketing of a pharma (Basic)
Marketing of a pharma (Basic)
 
Pakistan economy and debts on pakistan
Pakistan economy and debts on pakistanPakistan economy and debts on pakistan
Pakistan economy and debts on pakistan
 
Glaxosmithkline portfolio
Glaxosmithkline portfolioGlaxosmithkline portfolio
Glaxosmithkline portfolio
 

Similar to Pakistan Pharma Overview

Pharmaceutical Industry Analytics
Pharmaceutical Industry AnalyticsPharmaceutical Industry Analytics
Pharmaceutical Industry AnalyticsJatin Arora
 
Pharma marketing & policies
Pharma marketing & policiesPharma marketing & policies
Pharma marketing & policiesMursalin Ahmad
 
PMRG 2008 Presentation
PMRG 2008 PresentationPMRG 2008 Presentation
PMRG 2008 PresentationDavid Lester
 
2014 Profile: Biopharmaceutical Research Industry
2014 Profile: Biopharmaceutical Research Industry2014 Profile: Biopharmaceutical Research Industry
2014 Profile: Biopharmaceutical Research IndustryPhRMA
 
Newtech advant-business-plan9
Newtech advant-business-plan9Newtech advant-business-plan9
Newtech advant-business-plan9Yousaf Khan
 
Challenges of pharmaceutical industry in 2015
Challenges of pharmaceutical industry in 2015Challenges of pharmaceutical industry in 2015
Challenges of pharmaceutical industry in 2015yahyasultan
 
The future of pharma marketing
The future of pharma marketingThe future of pharma marketing
The future of pharma marketingFarhad Zargari
 
Prescription Medicines Costs in Context April 2021
Prescription Medicines Costs in Context April 2021Prescription Medicines Costs in Context April 2021
Prescription Medicines Costs in Context April 2021PhRMA
 
Read Logica’s paper on the need for convergence of healthcare and pharma
Read Logica’s paper on the need for convergence of healthcare and pharmaRead Logica’s paper on the need for convergence of healthcare and pharma
Read Logica’s paper on the need for convergence of healthcare and pharmaCGI
 
Ims global use_of_meds_report_2013
 Ims global use_of_meds_report_2013 Ims global use_of_meds_report_2013
Ims global use_of_meds_report_2013Utai Sukviwatsirikul
 
Wiekang Biotech Investor Presentation, June 2010
Wiekang Biotech Investor Presentation, June 2010Wiekang Biotech Investor Presentation, June 2010
Wiekang Biotech Investor Presentation, June 2010GeoInvesting LLC
 
Pharmaceutical Marketing Management
Pharmaceutical Marketing ManagementPharmaceutical Marketing Management
Pharmaceutical Marketing ManagementSheraz Pervaiz
 
Healthcasts_Whitepaper_5_Key_Physician_Insights_Pharma_Needs_to_Know
Healthcasts_Whitepaper_5_Key_Physician_Insights_Pharma_Needs_to_KnowHealthcasts_Whitepaper_5_Key_Physician_Insights_Pharma_Needs_to_Know
Healthcasts_Whitepaper_5_Key_Physician_Insights_Pharma_Needs_to_KnowDebra Harris
 
IMS - Global Use of Medicines 2020 by Nitesh Bhele
IMS - Global Use of Medicines 2020 by Nitesh BheleIMS - Global Use of Medicines 2020 by Nitesh Bhele
IMS - Global Use of Medicines 2020 by Nitesh BheleNitesh Bhele
 
Investigation of the accessibility and affordability of medicines in speciali...
Investigation of the accessibility and affordability of medicines in speciali...Investigation of the accessibility and affordability of medicines in speciali...
Investigation of the accessibility and affordability of medicines in speciali...Cornelis Jan Diepeveen
 
Prescription Medicines Costs in Context July 2021
Prescription Medicines Costs in Context July 2021Prescription Medicines Costs in Context July 2021
Prescription Medicines Costs in Context July 2021PhRMA
 

Similar to Pakistan Pharma Overview (20)

Pharmaceutical Industry Analytics
Pharmaceutical Industry AnalyticsPharmaceutical Industry Analytics
Pharmaceutical Industry Analytics
 
Pharmaceutical Supply Chain Dynamics and Intelligence
Pharmaceutical Supply Chain Dynamics and IntelligencePharmaceutical Supply Chain Dynamics and Intelligence
Pharmaceutical Supply Chain Dynamics and Intelligence
 
Pharma marketing & policies
Pharma marketing & policiesPharma marketing & policies
Pharma marketing & policies
 
PMRG 2008 Presentation
PMRG 2008 PresentationPMRG 2008 Presentation
PMRG 2008 Presentation
 
2014 Profile: Biopharmaceutical Research Industry
2014 Profile: Biopharmaceutical Research Industry2014 Profile: Biopharmaceutical Research Industry
2014 Profile: Biopharmaceutical Research Industry
 
Newtech advant-business-plan9
Newtech advant-business-plan9Newtech advant-business-plan9
Newtech advant-business-plan9
 
Challenges of pharmaceutical industry in 2015
Challenges of pharmaceutical industry in 2015Challenges of pharmaceutical industry in 2015
Challenges of pharmaceutical industry in 2015
 
The future of pharma marketing
The future of pharma marketingThe future of pharma marketing
The future of pharma marketing
 
Prescription Medicines Costs in Context April 2021
Prescription Medicines Costs in Context April 2021Prescription Medicines Costs in Context April 2021
Prescription Medicines Costs in Context April 2021
 
Final
FinalFinal
Final
 
Read Logica’s paper on the need for convergence of healthcare and pharma
Read Logica’s paper on the need for convergence of healthcare and pharmaRead Logica’s paper on the need for convergence of healthcare and pharma
Read Logica’s paper on the need for convergence of healthcare and pharma
 
Generic drug
Generic drugGeneric drug
Generic drug
 
Tech opens a window for OTC
Tech opens a window for OTCTech opens a window for OTC
Tech opens a window for OTC
 
Ims global use_of_meds_report_2013
 Ims global use_of_meds_report_2013 Ims global use_of_meds_report_2013
Ims global use_of_meds_report_2013
 
Wiekang Biotech Investor Presentation, June 2010
Wiekang Biotech Investor Presentation, June 2010Wiekang Biotech Investor Presentation, June 2010
Wiekang Biotech Investor Presentation, June 2010
 
Pharmaceutical Marketing Management
Pharmaceutical Marketing ManagementPharmaceutical Marketing Management
Pharmaceutical Marketing Management
 
Healthcasts_Whitepaper_5_Key_Physician_Insights_Pharma_Needs_to_Know
Healthcasts_Whitepaper_5_Key_Physician_Insights_Pharma_Needs_to_KnowHealthcasts_Whitepaper_5_Key_Physician_Insights_Pharma_Needs_to_Know
Healthcasts_Whitepaper_5_Key_Physician_Insights_Pharma_Needs_to_Know
 
IMS - Global Use of Medicines 2020 by Nitesh Bhele
IMS - Global Use of Medicines 2020 by Nitesh BheleIMS - Global Use of Medicines 2020 by Nitesh Bhele
IMS - Global Use of Medicines 2020 by Nitesh Bhele
 
Investigation of the accessibility and affordability of medicines in speciali...
Investigation of the accessibility and affordability of medicines in speciali...Investigation of the accessibility and affordability of medicines in speciali...
Investigation of the accessibility and affordability of medicines in speciali...
 
Prescription Medicines Costs in Context July 2021
Prescription Medicines Costs in Context July 2021Prescription Medicines Costs in Context July 2021
Prescription Medicines Costs in Context July 2021
 

Pakistan Pharma Overview